Osaic Holdings’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
TCM
SCM
RCM
BCM
Osaic Holdings's CAPR Position: Q2 2026 in Review
Osaic Holdings reduced its Capricor Therapeutics (CAPR) stake by 43% in Q2 2026, selling an estimated $473K and leaving 20,334 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #3690.
Osaic Holdings first reported a position in CAPR in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.66M in Q3 2024. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.
- Osaic Holdings held 20,334 shares of Capricor Therapeutics worth $490K as of Q2 2026.
- Osaic Holdings sold 15,616 Capricor Therapeutics shares in Q2 2026, an estimated $473K.
- Capricor Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3690 holding.
- Osaic Holdings first reported a position in Capricor Therapeutics in Q3 2021 and has held it in 20 quarters since.
- Osaic Holdings's Capricor Therapeutics position peaked at $3.66M in Q3 2024.
- 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.